Attenuated response to fourth dose SARS-CoV-2 vaccination in patients with autoimmune disease: a case series-Reference-Cited by-同舟云学术

Attenuated response to fourth dose SARS-CoV-2 vaccination in patients with autoimmune disease: a case series

Published:2022-01-17 Issue:5 Volume:81 Page:738-740
ISSN:0003-4967
Container-title:Annals of the Rheumatic Diseases
language:en
Short-container-title:Ann Rheum Dis

Author:

Teles Mayan,Connolly Caoilfhionn M^ORCID,Frey Sarah,Chiang Teresa Po-Yu,Alejo Jennifer J^ORCID,Boyarsky Brian J^ORCID,Shah Ami A,Albayda Jemima,Christopher-Stine Lisa,Werbel William A,Segev Dorry L^ORCID,Paik Julie J^ORCID

Funder

National Institute of Arthritis and Musculoskeletal and Skin Diseases

National Institute of Diabetes and Digestive and Kidney Diseases

National Institute of Allergy and Infectious Diseases

Publisher

BMJ

Subject

General Biochemistry, Genetics and Molecular Biology,Immunology,Immunology and Allergy,Rheumatology

Reference7 articles.

1. BNT162b2 vaccine breakthrough: clinical characteristics of 152 fully vaccinated hospitalized COVID-19 patients in Israel;Brosh-Nissimov;Clin Microbiol Infect,2021

2. Booster-dose SARS-CoV-2 vaccination in patients with autoimmune disease: a case series

3. AB0634 BELIEFS ABOUT URATE LOWERING THERAPY DIFFER BETWEEN GENERAL PRACTITIONERS AND RHEUMATOLOGISTS

4. Quantitative measurement of Anti-SARS-CoV-2 antibodies: analytical and clinical evaluation;Higgins;J Clin Microbiol,2021

5. Antibody response to a fourth dose of a SARS-CoV-2 vaccine in solid organ transplant recipients: a case series;Alejo;Transplantation,2021

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prevalence and Risk Factors of Postacute Sequelae of COVID-19 in Adults With Systemic Autoimmune Rheumatic Diseases;The Journal of Rheumatology;2024-07-01

2. Immunogenicity, clinical efficacy and safety of additional second COVID‐19 booster vaccines against Omicron and its subvariants: A systematic review;Reviews in Medical Virology;2024-01

3. Effectiveness of a fourth dose of COVID-19 mRNA vaccine in patients with systemic autoimmune rheumatic diseases using disease-modifying antirheumatic drugs: an emulated target trial;The Lancet Rheumatology;2024-01

4. Innovation-driven trend shaping COVID-19 vaccine development in China;Frontiers of Medicine;2023-12-16

5. Effectiveness and waning of protection with the BNT162b2 vaccine against the SARS-CoV-2 Delta variant in immunocompromised individuals;Frontiers in Immunology;2023-11-02